You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Accuracy rate and rate of each unanswered question

From: Assessment of neurologists’ knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China

Questions Correct responses Unanswered
n % (95% CI) n %
1. Time window for intravenous fibrinolysis 85 64.9 (56.02–72.89) 1 0.8
2. Imaging results required before fibrinolysis 109 83.2 (75.45–88.95) 0 0
3. Laboratory results required before fibrinolysis 1 0.8 (0.05–4.87) 0 0
4. Dose of alteplase 87 66.4 (57.55–74.27) 3 2.3
5. Maximum dose of alteplase 67 51.1 (42.26–59.88) 4 3.1
6. Whether to thrombolyse if hypodensity > 1/3 MCA territory on CT 126 96.2 (90.89–98.6) 3 2.3
7. Whether to thrombolyse if patients had prior ischemic stroke within 2 months 84 64.1 (55.20–72.16) 2 1.5
8. Whether to thrombolyse if patients had previous intracranial hemorrhage 69 52.7 (43.82–61.42) 5 3.8
9. Whether to thrombolyse if NIHSS > 25 within 3 h from symptom onset 45 34.4 (26.46–43.27) 2 1.5
10. Whether to stop thrombolyse if patients develop skin, mucosa or gum bleeding 62 47.3 (38.58–56.18) 1 0.8
11. Whether to stop thrombolyse if patients develop severe vomiting 42 32.1 (24.37–40.9) 1 0.8
12. Whether to stop thrombolyse if patients develop worsening neurological examinations 86 65.6 (56.73–73.54) 1 0.8
  1. MCA middle cerebral artery, CT computed tomography